Coexistence of Graves’ disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels
✍ Scribed by Guida, M.; Mandato, V. D.; Di Spiezio Sardo, A.; Di Carlo, C.; Giordano, E.; Nappi, C.
- Book ID
- 125337434
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 346 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0391-4097
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The presence of CA 125, an ovarian cancer-associated antigen, was assessed in serum and ascites from patients with ovarian cancer (n = 47), hepatocellular carcinoma (n = 21), and liver cirrhosis (n = 40). Abnormal levels of serum CA 125 were observed in 49% of ovarian cancer patients, and in 89% of
## Abstract Elevated plasma levels of apolipoprotein (a) have been reported earlier in cancer patients. In order to investigate the potential of apolipoprotein(a) as an ovarian tumour marker, plasma apolipoprotein(a) and CA125 levels were measured in healthy women and women with benign or malignant